Navigation Links
CBI and PharmaVoice Announce Recipients of the Strategic Patient Adherence Awards
Date:4/30/2008

WOBURN, Mass., April 30 /PRNewswire/ -- AstraZeneca, Eli Lilly and Rx Canada received top honors at the 2008 Strategic Patient Adherence (SPA) Awards. Rx Canada and their client (AstraZeneca Canada), the first international award winners, received awards for the Best Branded Compliance Program. The Health Inform(R) Programs for Crestor, Symbicort and Nexium medications were lauded for measurement of each program's effectiveness. "I really liked the way in which they measured and published their results," said Robert Nauman, BioPharma Advisors and a judge for the SPA awards. Rx Canada and their client (Eli Lilly Canada) received an innovation award for the Evista Inner Strength Program which ensured that pharmacists followed up with patients 2 weeks after their first intervention. Finally, AstraZeneca received an innovation award for the SERV(TM) Program, which is a platform that allows AZ brands to leverage the sales force to provide messages, tools and programs to physicians toward enhancing medication adherence in their patients.

The prestigious Strategic Patient Adherence (SPA) Awards co-sponsored by CBI and PharmaVoice were presented at the 7th Annual Forum on Patient Compliance, Adherence and Persistency held April 24th in Philadelphia, PA. These awards provided a forum that pays tribute to outstanding programs in the areas of patient compliance/adherence and persistency.

Awards were given to pharmaceutical organizations that met pre-defined criteria in 5 categories: Innovation, Quality, Measurement, Satisfaction, Health Outcomes & ROI. Programs that have been deemed exceptional in their compliance initiatives usually score above 60 points on the judging scale. Each entry was reviewed by this year's judging panel made up of Grant Corbett, Founder of Behavior Change Solutions, Inc., Robert Nauman, Principal at BioPharma Advisors, John Heilman, Senior Commercial Analytics Manager, New Practice and Corporate Analytics, AstraZeneca, Glenn Gary, Senior Marketing Manager, Amgen, and Dorothy L. Smith, Pharm.D, President of Consumer Health Information. Both John and Gary are previous award winners of the SPA award.

"The SPA awards were a success because these programs incorporate the best practices that occur in the industry today. This year's winners proved the value and validity against some nationally recognized criteria for patient compliance, adherence and persistency programs," said Grant Corbett, Principal, Behavior Change Solutions and a judge for the SPA awards.

For information about next year's awards please contact Jackie Harrington at 781-939-2405 or Email: Jackie.harrington@cbinet.com

About CBI Research, Inc. (http://www.cbinet.com)

Founded in 1994 in Massachusetts, CBI Research, Inc. is dedicated to developing market-driven, unbiased conferences in pharmaceuticals\biotech, medical devices, risk and insurance and managed care markets. CBI Research, Inc. offers conferences and summits that serve senior executives and government officials by providing a unique platform for highly focused content and presentation. As a delegate, speaker or sponsor, you receive timely information on the latest investment opportunities, business strategies, domestic and international regulatory issues, operations and applied technologies. Our events provide you with concrete, real life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. Plus, there are extensive opportunities for networking and discussion with senior policy and decision makers. CBI Research, Inc. was acquired by Advanstar Communications, Inc. in February of 2008.


'/>"/>
SOURCE CBI Research, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
2. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
3. Beckman Coulter Announces First Quarter 2008 Results
4. Onyx Pharmaceuticals Announces First Quarter 2008 Financial Results Teleconference and Webcast
5. BioMarin Announces First Quarter 2008 Financial Results
6. Align Technology Announces $50 Million Stock Repurchase Program
7. Anesiva Announces New Zingo Marketing and Distribution Agreement
8. Premier Research Group plc and Octagon Research Solutions, Inc. Announce Strategic Partnership
9. Genomic Health to Announce First Quarter 2008 Financial Results and Host Conference Call on Tuesday, May 6, 2008
10. Webcast Alert: QIAGEN N.V. Announces First Quarter 2008 Earnings Conference Call
11. Syndexa Pharmaceuticals Corporation and ChemDiv, Inc. Announce Discovery Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... ... The American Academy of Thermology (AAT) has announced that for the ... Qualification Course for Technicians via a two part webinar on July 30 and August ... of hardware, software, and camera setup/operations, aligns with the in-person member qualification course that ...
(Date:2/9/2016)... This market research report on the global ... of the market in terms of revenue (USD Million). ... the manufacture of microbiology culture media and related products. ... snapshot providing the overall information of various market segments ... also provides the overall information and data analysis of ...
(Date:2/9/2016)... DelveInsight,s, "Protein-Tyrosine Phosphatase ... in depth insights on the pipeline drugs ... Phosphatase 1B (PTP1B) Inhibitors. The DelveInsight,s Report ... of development including Discovery, Pre-clinical, IND, Phase ... Report covers the product clinical trials information ...
(Date:2/8/2016)... February 8, 2016 ... Limited, an innovation-driven oncology company developing next generation ... toxic, today announced that chairman emeritus of Tata ... in the company as part of the first ... existing investors Navam Capital and Aarin Capital. ...
Breaking Biology Technology:
(Date:2/2/2016)... NEW YORK , Feb. 2, 2016 /PRNewswire/ ... Potentials of that Rising Market Are you ... new analysis forecasts revenues for checkpoint inhibitors. Visiongain,s ... world market, submarket, product and national level. ... Instead discover what progress, opportunities and revenues those ...
(Date:2/1/2016)... 2016  Today, the first day of American Heart ... develop a first of its kind workplace health solution ... In the first application of Watson ... ), and Welltok will create a new offering that ... analytics, delivered on Welltok,s health optimization platform. The effort ...
(Date:1/25/2016)... Software, the world-leading supplier of image data management solutions ... data management solution OMERO Plus for the newly established ... Photo - http://photos.prnewswire.com/prnh/20160125/325328LOGO ... analysis measures the characteristics and behavior of cells, tissues ... as health and disease, the presence or absence of ...
Breaking Biology News(10 mins):